Quasar Medical Acquires Nordson's Manufacturing Units, Enhancing CDMO Capabilities and Innovation

Quasar Medical Expands Its Horizons with Nordson Acquisition

Quasar Medical takes a substantial step forward in the medical device sector by acquiring Nordson Corporation's design and development contract manufacturing businesses located in Galway, Ireland, and Tecate, Mexico. This strategic acquisition transforms Quasar into a fully integrated Contract Development and Manufacturing Organization (CDMO), enabling the company to provide comprehensive solutions from concept to commercialization for medical device original equipment manufacturers (OEMs) and innovators. This evolution not only enhances Quasar's operational capabilities but also signifies a pivotal moment in its growth trajectory, allowing it to tap into new markets and reinforce its competitive edge.

The acquisition is set to bolster Quasar's workforce by nearly 200 skilled professionals, including development engineers and technicians, thereby creating significant employment opportunities. CEO Alex Wallstein highlights that this expansion enhances the company's global footprint and strengthens its partnerships with customers and suppliers throughout the entire product lifecycle. By integrating the resources and expertise from the newly acquired facilities, Quasar aims to drive innovation and accelerate time-to-market for its clients, addressing the increasing demand for advanced medical devices.

The Galway and Tecate facilities, both FDA-registered and ISO 13485-certified, are strategically located in key MedTech regions, providing crucial proximity to customers and improving access to resources. The Galway site is envisioned as an innovation hub, focusing on advanced product design, prototyping, and clinical innovation, while the Tecate facility will specialize in high-volume manufacturing at a cost-effective scale. COO Aviel Bohnik notes that this acquisition positions Quasar not merely as a manufacturer but as a strategic partner, offering a differentiated platform that emphasizes innovation, scalability, and operational excellence. By leveraging Nordson Medical's capabilities, Quasar is now equipped to deliver seamless, end-to-end solutions for complex interventional devices, reinforcing its commitment to high-value offerings across global markets.

In addition to the workforce expansion, Quasar's acquisition of Nordson's facilities positions the company to better serve the evolving needs of the medical device industry. By enhancing its manufacturing capabilities and fostering innovation, Quasar is poised to respond more effectively to the demands of OEMs and innovators seeking reliable partners in the competitive MedTech landscape. The integration of these assets not only strengthens Quasar's operational infrastructure but also underscores its ambition to lead in the CDMO space.

Overall, this strategic move by Quasar Medical exemplifies its commitment to enhancing its service offerings and solidifying its position within the medical device manufacturing sector. The company is set to play a crucial role in the development of new medical technologies, ensuring that it remains at the forefront of innovation in an industry that is constantly evolving.